Literature DB >> 30309679

LRP5 controls cardiac QT interval by modulating the metabolic homeostasis of L-type calcium channel.

Dandan Liang1, Yahan Wu1, Liping Zhou1, Yongli Chen2, Hongyu Liu1, Duanyang Xie1, Jian Huang1, Yangyang Zhang1, Yi Liu1, Weidong Zhu3, Jun Li4, Yi-Han Chen5.   

Abstract

BACKGROUND: Low-density lipoprotein receptor-related protein 5 (LRP5) has been intensively studied as a co-receptor for β-catenin-dependent Wnt signaling. Emerging evidences have demonstrated β-catenin-independent functions of LRP5. However, the biological role of LRP5 in the mammalian heart is largely unknown. METHODS AND
RESULTS: Conditional cardiac-specific Lrp5 knockout (Lrp5-CKO) mice were generated by crossing Lrp5flox/flox mice with αMHC/MerCreMer mice. Lrp5-CKO mice consistently displayed normal cardiac structure and function. Telemetric electrocardiogram recordings revealed a short QT interval in Lrp5-CKO mice, which was tightly linked to the striking abbreviation of action potential duration (APD) in ventricular myocytes. The analysis of whole-cell currents indicated that a reduction in activity and protein expression of L-type calcium channel (LTCC), rather than other ion channels, contributed to the abnormality in APD. Furthermore, we showed that Lrp5 ablation induced a significant convergence of CaV1.2α1c proteins to the endoplasmic reticulum. Consequently, increased proteasomal degradation of these proteins was observed, which was independent of the Wnt/β-catenin signaling pathway.
CONCLUSIONS: LRP5 directly modulates the degradation of LTCC to control cardiac QT interval. These findings provide compelling evidence for the potential role of LRPs in cardiac electrophysiology.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Action potential duration; L-type calcium channel; Low-density lipoprotein receptor-related protein; Myocyte; Proteasomal degradation; QT interval

Mesh:

Substances:

Year:  2018        PMID: 30309679     DOI: 10.1016/j.ijcard.2018.06.029

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Metformin Shortens Prolonged QT Interval in Diabetic Mice by Inhibiting L-Type Calcium Current: A Possible Therapeutic Approach.

Authors:  Hui Wang; Cao Wang; Yuan Lu; Yan Yan; Dongjing Leng; Shanshan Tian; Dongjie Zheng; Zhiguo Wang; Yunlong Bai
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

2.  LRP5 regulates cardiomyocyte proliferation and neonatal heart regeneration by the AKT/P21 pathway.

Authors:  Huixing Zhou; Fulei Zhang; Yahan Wu; Hongyu Liu; Ran Duan; Yuanyuan Liu; Yan Wang; Xiaoyu He; Yuemei Zhang; Xiue Ma; Yi Guan; Yi Liu; Dandan Liang; Liping Zhou; Yi-Han Chen
Journal:  J Cell Mol Med       Date:  2022-04-16       Impact factor: 5.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.